Clinical Trials Logo

Clinical Trial Summary

The purpose of the study was to evaluate lung clearance index (LCI) by a standardized procedure in a well characterized study setting and to assess feasibility of LCI as a more sensitive method than forced expiratory volume at 1 second (FEV1) to measure effectiveness of antibiotic therapy in patients with CF aged 6 years and older with mild to moderate lung disease.


Clinical Trial Description

This study was terminated prematurely. The reason for trial termination was challenge with enrollment and patient recruitment. A significant decrease in the eligible patient population had been identified as main driver. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02248922
Study type Interventional
Source Novartis
Contact
Status Terminated
Phase Phase 4
Start date January 27, 2015
Completion date April 10, 2017